Navigation Links
Nuvelo Announces Publication of Phase 2 rNAPc2 Study Results in,Journal of American College of Cardiology

SAN CARLOS, Calif., June 19, 2007 /PRNewswire-FirstCall/ -- Nuvelo, Inc. today announced the publication of the Phase 2 proof-of-concept data from the Anthem (Anticoagulation with rNAPc2 To Help Eliminate MACE)/TIMI 32 clinical trial (N=255) in the June 26th issue of the Journal of of Cardiology (JACC), demonstrating that higher-dose (greater than or equal to 7.5 mcg/kg) recombinant nematode anticoagulant protein c2 (rNAPc2) reduced the incidence and duration of ischemia as measured by 7-day continuous electrocardiogram (ECG) by more than 50% and did not statistically significantly increase bleeding in patients being treated with standard antithrombotics and an early invasive approach for non-ST-elevation acute coronary syndromes (NSTE-ACS).

"In clinical studies of other antithrombotics, suppression of ischemia monitored by continuous ECG has been associated with a reduction in clinical ischemic events," said Dr. Robert Giugliano, M.D., S.M., Investigator, TIMI Study Group, Associate Physician, Brigham and Women's Hospital and Assistant Professor of Medicine, Harvard Medical School. "In the ANTHEM/TIMI 32 trial, the ability of higher-dose rNAPc2 to reduce ischemia in patients that are already receiving antithrombotic therapy is very exciting, and we look forward to future studies to further understand rNAPc2's potential in this patient population."

ANTHEM/TIMI 32 Study Details and Results

The ANTHEM/TIMI 32 trial consisted of two stages, a dose escalation safety stage and a heparin replacement stage. All patients in the study had 3-lead Holter monitors for assessment of cardiac ischemia, measurement of prothrombin time and F1+2 concentration, and clinical follow-up for up to six months.

The first stage was a double-blind, placebo-controlled, dose escalation study which investigated the safety of rNAPc2 in combination with other antithrombotics in 203 patients with NSTE-ACS. These dat
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Nuvelo Announces Presentations on rNAPc2 and NU172 at the XXIst Congress of the International Society on Thrombosis and Haemostasis
2. Nuvelo Announces Publication of Preclinical Study Results Demonstrating the Potential of NTB-A as a New Target for Leukemia and Lymphomas
3. Nuvelo Announces Publication of NU206 Study Results in Gastroenterology
4. Nuvelo Announces Presentation on NU206 at 2007 American Association for Cancer Research Annual Meeting
5. Nuvelo Announces Presentation on rNAPc2 at American College of Cardiology 56th Annual Scientific Session
6. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
7. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
9. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
10. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
11. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis

Post Your Comments:
(Date:11/20/2009)...rstCall/ -- Cornerstone Therapeutics Inc. (Nasdaq:...ed on acquiring, developing and commercializing si...nd related markets, today reported that it had rec...nistration ("FDA") alleging that its Deconsal CT c...ne Maleate 16 mg) and Deconsal DM chewable tablets...
(Date:11/20/2009)... -- Reportlinker.com announces that a new market r..., Blood Pressure Monitoring & Measurement Ins.../www.reportlinker.com/p0164309/Blood-Pressure-Moni...nalysis.html#utm_source=prnewswire&utm_medium=... of blood pressure is not only an indicator of car...
(Date:11/20/2009)... -- Reportlinker.com announces that a new market r..., Global Markets for Assisted Reproductive Device...42/Global-Markets-for-Assisted-Reproductive-Device...r&utm_campaign=prnewswire ,, Global Marke...ountries in Europe and Japan. This report includes...
Breaking Medicine Technology:Cornerstone Therapeutics Provides a Response to FDA Warning Letter on Deconsal 2Cornerstone Therapeutics Provides a Response to FDA Warning Letter on Deconsal 3Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 2Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 3Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 4Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 5Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 6Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 7Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 8Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 9Reportlinker Adds Global Markets for Assisted Reproductive Devices 2009 2SedationFacts org Presents Content on Policies and Conditions Regarding Alternative Methods for the Administration of Propofol 52439 1SedationFacts org Presents Content on Policies and Conditions Regarding Alternative Methods for the Administration of Propofol 52439 2SedationFacts org Presents Content on Policies and Conditions Regarding Alternative Methods for the Administration of Propofol 52439 3SedationFacts org Presents Content on Policies and Conditions Regarding Alternative Methods for the Administration of Propofol 52439 4Life lessons 3A Where psychology stands on living well 52437 1Life lessons 3A Where psychology stands on living well 52437 2American Academy of Orthopaedic Surgeons approves new guideline for the treatment of pediatric diaphyseal femur fractures 52434 1American Academy of Orthopaedic Surgeons approves new guideline for the treatment of pediatric diaphyseal femur fractures 52434 2
..., N.J., May 20 Palatin Technologies,Inc. (Amex: ...ed in a Phase,2a clinical study of PL-3994, a nove...ist, in subjects with controlled hypertension., T... and will include up,to five cohorts receiving esc...uded, with six active subjects and one placebo sub...
...E, Md., May 19 On Thursday May 15,2008 Sanaria In...nnual,Technology Council of Maryland,s Tech Awards...rs and organizations., http://techcouncilmd.com/...e Sanaria team go to work every day with only one,...nt millions of deaths,from malaria," said Sanaria ...
Other Medicine Technology:Palatin Technologies Initiates Phase 2 Hypertension Clinical Study With PL-3994 2Palatin Technologies Initiates Phase 2 Hypertension Clinical Study With PL-3994 3Malaria Vaccine Developer Sanaria Inc. Receives the Technology Council of Maryland's Emerging Company of the Year Award 2
(Date:11/23/2009)... Information about Oxycodone use is now just....com. The new site is a statistical database that ...done in each county in the United States. The data... drug for recreational or medicinal use. , ... 23, 2009 -- Legal and illegal Oxycodone statisti...
(Date:11/23/2009)...3/PRNewswire/--Dr.Siegal,sDirectNutritionals,LLC,w...oductsandoperatorofwebsiteCookieDiet.com( www.Cook...SanfordSiegal,sever-popularhunger-satisfyingcookie...membershipdiscountclub,Sam,sClub. ,, "We,reprou...ilersthatcarryDr.Siegal,sCookieDietproducts,andthe...
(Date:11/23/2009)...R,Mass.,Nov.23/PRNewswire/--Thistimeofyearbringslo...enthesefeelings,bothpositiveandnegative,translatei...rearelotsofopportunitiestodosoallseasonlong. ,,...epie,buthowmanyofusstopthere?"Thatpieoftenopensthe...asonafterholidayseasontellingourselvestohavejuston...
(Date:11/23/2009)...ov.23/PRNewswire/-- Withtheholidaysapproaching,on...rainchesandpounds. LadyFootLocker recommendsshoppe...ldothework.Withtherightfootwear,itcandoexactlythat...h/20091123/NYFNSU09 ) ,, Toningfootwearlike Re...mthemallintoapersonalgym.Burncalories,andtoneyourg...
(Date:11/23/2009)... N.C. For the first time, scientists have demonst... an important test of potential to become speciali...for treating a wider array of diseases and conditi...ing in Oncogene , a publication of Nature Publish...D., director of the Wake Forest Institute for Rege...
Breaking Medicine News(10 mins):Health News:DopeStats.com Provides Statistics on Oxycodone Abused in Non-Medical Purposes 2Health News:Dr. Siegal's COOKIE DIET(R) Cookies Available at Samsclub.com 2Health News:Tis' the Season to Eat and Eat More! 2Health News:Make the Most of Your Holiday Haul with Lady Foot Locker 2Health News:New research shows versatility of amniotic fluid stem cells 2
...ns based on prostate cancer biopsy were found to b...his measurement could help predict the risk of pro...research published in the October 3 issue of JAMA....mors) of the prostate based on the patterns of pro...
...ime Designs in October Donated to ... Oct. 2 Smilebox, Inc., the leader in,multimedia ...dia greeting,and scrapbook designs in recognition ...fered at, http://www.lifetimetv.com/breastcancer, ...
...ch announced the,findings of the latest wave of it...rvey was completed in late June and found that jus...rage are definitely or very likely,to switch to MA...switch, general satisfaction with their current,co...
...ge Animal Health, a,division of Wyeth (NYSE: WYE ...oners (AAFP) today launched http://www.healthycat...al program that provides resources for cat,owners ...lashcards and practical tips on a broad range of f...
...tt,Romney is back in Boston today, one day after r...campaign trail. Asked by a reporter in Missouri if...th insurance to 3.8 million,uninsured children by ...n said "It,s unfortunate the Democrats used,this v...
...campaigns in Iowa today, Iowa voters will want to ...t Bush,s threat to veto health care coverage for,1... Iowa,s kids.,[ http://www.governor.iowa.gov/news/..., the,successful SCHIP program enjoys the broad bi...
Other Medicine News:Health News:Using additional biopsy-scoring data may help determine prostate cancer prognosis 2Health News:Smilebox and Lifetime Television Promote Breast Cancer Awareness With Multimedia Designs for Sending Mammogram Reminders and Celebrating Courage 2Health News:Fort Dodge Animal Health and the American Association of Feline Practitioners Launch Educational Web Site for Cat Owners - www.healthycatsforlife.com 2Health News:DNC: Romney Chooses President Bush Over Uninsured Children 2Health News:DNC: Romney Chooses President Bush Over Uninsured Children 3Health News:DNC: Fred Thompson Stands With President Bush, Not Iowa's Kids 2
...t Aberrometer is an innovative diagnostic instrume...care practitioners and researchers to effectively ... a subjects eye. This remarkable device offers the...n more than 99% of subjects. Beyond its superior p...
...e implant that is used for covering trephination b...-friendly design, shaped like a flattened button m...uires no fixation by screws, unlike titanium plate...ffold architecture minimizes potential injuries to...
RTX3370 Telehealth Monitor
Specialized Coagulation Testing
Medicine Products: